Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature.

Saved in:
Bibliographic Details
Title: Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature.
Authors: Whitworth PW; Nashville Breast Center, Nashville, TN.; Targeted Medical Education, Cupertino, CA., Beitsch PD; Targeted Medical Education, Cupertino, CA.; Dallas Surgical Group, Dallas, TX., Pellicane JV; Bon Secours Cancer Institute, Richmond, VA., Baron PL; Breast and Melanoma Specialist of Charleston, Charleston, SC.; Lenox Hill Hospital/Northwell Health, New York, NY., Lee LA; Comprehensive Cancer Center, Palm Springs, CA., Dul CL; Ascension St John Hospital Great Lakes Cancer Management Specialists, Grosse Pointe Woods, MI., Murray MK; Akron General Medical Center, Akron, OH.; Cleveland Clinic Akron General, Akron, OH., Gittleman MA; Breast Care Specialists, Allentown, PA., Budway RJ; St Clair Hospital, Pittsburgh, PA., Rahman RL; Texas Tech University, Lubbock, TX., Kelemen PR; Ashikari Breast Center, Sleepy Hollow, NY.; Zucker School of Medicine, Hofstra University, Hempstead, NY., Dooley WC; Breast Institute, University of Oklahoma Health Sciences, Oklahoma City, OK.; Stephenson Cancer Center, Oklahoma City, OK., Rock DT; Regional Breast Care, Fort Myers, FL.; Genesis Care, Fort Myers, FL., Cowan KH; Fred and Pamela Buffet Cancer Center and Eppley Institute for Research in Cancer at University of Nebraska Medical Center, Omaha, NE., Lesnikoski BA; The Breast Institute at JFK Medical Center, Atlantis, FL.; Baptist MD Anderson Cancer Center, Jacksonville, FL., Barone JL; Exempla Saint Joseph Hospital, Denver, CO.; Vail Health, Vail, CO., Ashikari AY; Zucker School of Medicine, Hofstra University, Hempstead, NY.; Northwell Health Physician Partners, Mount Kisco, NY., Dupree BB; St Mary Medical Alliance Cancer Specialists, Langhorne, PA., Wang S; Agendia Inc, Irvine, CA., Menicucci AR; Agendia Inc, Irvine, CA., Yoder EB; Agendia Inc, Irvine, CA., Finn C; Agendia Inc, Irvine, CA., Corcoran K; Agendia Inc, Irvine, CA., Blumencranz LE; Agendia Inc, Irvine, CA., Audeh W; Agendia Inc, Irvine, CA.
Corporate Authors: NBRST Investigators Group
Source: JCO precision oncology [JCO Precis Oncol] 2022 Apr; Vol. 6, pp. e2100463.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35476550
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Whitworth+PW%22">Whitworth PW</searchLink>; Nashville Breast Center, Nashville, TN.; Targeted Medical Education, Cupertino, CA.<br /><searchLink fieldCode="AU" term="%22Beitsch+PD%22">Beitsch PD</searchLink>; Targeted Medical Education, Cupertino, CA.; Dallas Surgical Group, Dallas, TX.<br /><searchLink fieldCode="AU" term="%22Pellicane+JV%22">Pellicane JV</searchLink>; Bon Secours Cancer Institute, Richmond, VA.<br /><searchLink fieldCode="AU" term="%22Baron+PL%22">Baron PL</searchLink>; Breast and Melanoma Specialist of Charleston, Charleston, SC.; Lenox Hill Hospital/Northwell Health, New York, NY.<br /><searchLink fieldCode="AU" term="%22Lee+LA%22">Lee LA</searchLink>; Comprehensive Cancer Center, Palm Springs, CA.<br /><searchLink fieldCode="AU" term="%22Dul+CL%22">Dul CL</searchLink>; Ascension St John Hospital Great Lakes Cancer Management Specialists, Grosse Pointe Woods, MI.<br /><searchLink fieldCode="AU" term="%22Murray+MK%22">Murray MK</searchLink>; Akron General Medical Center, Akron, OH.; Cleveland Clinic Akron General, Akron, OH.<br /><searchLink fieldCode="AU" term="%22Gittleman+MA%22">Gittleman MA</searchLink>; Breast Care Specialists, Allentown, PA.<br /><searchLink fieldCode="AU" term="%22Budway+RJ%22">Budway RJ</searchLink>; St Clair Hospital, Pittsburgh, PA.<br /><searchLink fieldCode="AU" term="%22Rahman+RL%22">Rahman RL</searchLink>; Texas Tech University, Lubbock, TX.<br /><searchLink fieldCode="AU" term="%22Kelemen+PR%22">Kelemen PR</searchLink>; Ashikari Breast Center, Sleepy Hollow, NY.; Zucker School of Medicine, Hofstra University, Hempstead, NY.<br /><searchLink fieldCode="AU" term="%22Dooley+WC%22">Dooley WC</searchLink>; Breast Institute, University of Oklahoma Health Sciences, Oklahoma City, OK.; Stephenson Cancer Center, Oklahoma City, OK.<br /><searchLink fieldCode="AU" term="%22Rock+DT%22">Rock DT</searchLink>; Regional Breast Care, Fort Myers, FL.; Genesis Care, Fort Myers, FL.<br /><searchLink fieldCode="AU" term="%22Cowan+KH%22">Cowan KH</searchLink>; Fred and Pamela Buffet Cancer Center and Eppley Institute for Research in Cancer at University of Nebraska Medical Center, Omaha, NE.<br /><searchLink fieldCode="AU" term="%22Lesnikoski+BA%22">Lesnikoski BA</searchLink>; The Breast Institute at JFK Medical Center, Atlantis, FL.; Baptist MD Anderson Cancer Center, Jacksonville, FL.<br /><searchLink fieldCode="AU" term="%22Barone+JL%22">Barone JL</searchLink>; Exempla Saint Joseph Hospital, Denver, CO.; Vail Health, Vail, CO.<br /><searchLink fieldCode="AU" term="%22Ashikari+AY%22">Ashikari AY</searchLink>; Zucker School of Medicine, Hofstra University, Hempstead, NY.; Northwell Health Physician Partners, Mount Kisco, NY.<br /><searchLink fieldCode="AU" term="%22Dupree+BB%22">Dupree BB</searchLink>; St Mary Medical Alliance Cancer Specialists, Langhorne, PA.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Agendia Inc, Irvine, CA.<br /><searchLink fieldCode="AU" term="%22Menicucci+AR%22">Menicucci AR</searchLink>; Agendia Inc, Irvine, CA.<br /><searchLink fieldCode="AU" term="%22Yoder+EB%22">Yoder EB</searchLink>; Agendia Inc, Irvine, CA.<br /><searchLink fieldCode="AU" term="%22Finn+C%22">Finn C</searchLink>; Agendia Inc, Irvine, CA.<br /><searchLink fieldCode="AU" term="%22Corcoran+K%22">Corcoran K</searchLink>; Agendia Inc, Irvine, CA.<br /><searchLink fieldCode="AU" term="%22Blumencranz+LE%22">Blumencranz LE</searchLink>; Agendia Inc, Irvine, CA.<br /><searchLink fieldCode="AU" term="%22Audeh+W%22">Audeh W</searchLink>; Agendia Inc, Irvine, CA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22NBRST+Investigators+Group%22">NBRST Investigators Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101705370%22">JCO precision oncology</searchLink> [JCO Precis Oncol] 2022 Apr; Vol. 6, pp. e2100463.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101705370 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-4284 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224734284%22">24734284 </searchLink><i>NLM ISO Abbreviation: </i>JCO Precis Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35476550
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/PO.21.00463
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e2100463
    Titles:
      – TitleFull: Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Whitworth PW
      – PersonEntity:
          Name:
            NameFull: Beitsch PD
      – PersonEntity:
          Name:
            NameFull: Pellicane JV
      – PersonEntity:
          Name:
            NameFull: Baron PL
      – PersonEntity:
          Name:
            NameFull: Lee LA
      – PersonEntity:
          Name:
            NameFull: Dul CL
      – PersonEntity:
          Name:
            NameFull: Murray MK
      – PersonEntity:
          Name:
            NameFull: Gittleman MA
      – PersonEntity:
          Name:
            NameFull: Budway RJ
      – PersonEntity:
          Name:
            NameFull: Rahman RL
      – PersonEntity:
          Name:
            NameFull: Kelemen PR
      – PersonEntity:
          Name:
            NameFull: Dooley WC
      – PersonEntity:
          Name:
            NameFull: Rock DT
      – PersonEntity:
          Name:
            NameFull: Cowan KH
      – PersonEntity:
          Name:
            NameFull: Lesnikoski BA
      – PersonEntity:
          Name:
            NameFull: Barone JL
      – PersonEntity:
          Name:
            NameFull: Ashikari AY
      – PersonEntity:
          Name:
            NameFull: Dupree BB
      – PersonEntity:
          Name:
            NameFull: Wang S
      – PersonEntity:
          Name:
            NameFull: Menicucci AR
      – PersonEntity:
          Name:
            NameFull: Yoder EB
      – PersonEntity:
          Name:
            NameFull: Finn C
      – PersonEntity:
          Name:
            NameFull: Corcoran K
      – PersonEntity:
          Name:
            NameFull: Blumencranz LE
      – PersonEntity:
          Name:
            NameFull: Audeh W
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2022 Apr
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2473-4284
          Numbering:
            – Type: volume
              Value: 6
          Titles:
            – TitleFull: JCO precision oncology
              Type: main
ResultId 1